Gene: RAB31
Official Full Name: RAB31, member RAS oncogene familyprovided by HGNC
Gene Summary: Enables GDP binding activity and GTP binding activity. Involved in several processes, including Golgi to plasma membrane protein transport; cellular response to insulin stimulus; and receptor internalization. Located in early endosome; phagocytic vesicle; and trans-Golgi network membrane. Biomarker of severe acute respiratory syndrome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06040 | RAB31 Knockout cell line (HeLa) | Human | RAB31 | 1:3~1:6 | Negative | Online Inquiry |
KO06041 | RAB31 Knockout cell line (HCT 116) | Human | RAB31 | 1:2~1:4 | Negative | Online Inquiry |
KO06042 | RAB31 Knockout cell line (HEK293) | Human | RAB31 | 1:3~1:6 | Negative | Online Inquiry |
KO06043 | RAB31 Knockout cell line (A549) | Human | RAB31 | 1:3~1:4 | Negative | Online Inquiry |
RAB31 Gene Knockout Cell Lines are genetically engineered models specifically designed to facilitate the study of the RAB31 gene's role in cellular processes. These cell lines have been meticulously altered to eliminate the expression of the RAB31 gene, providing researchers with an invaluable tool for investigating its function and downstream effects in various biological contexts.
The primary function of RAB31 encompasses its role in intracellular transport and membrane dynamics. By knocking out this gene, researchers can delve into the mechanisms governing vesicle trafficking, exocytosis, and endocytosis, elucidating the implications of disrupted cellular signaling pathways. This experimental model is particularly vital for studies related to cancer biology, neurodegenerative disorders, and metabolic diseases, where RAB31's involvement may significantly influence disease progression and therapeutic responses.
The scientific importance of RAB31 Gene Knockout Cell Lines lies in their application across multiple fields of research. These models can be employed in drug discovery, enabling the identification of novel therapeutic targets, or in gene function studies, where the influence of RAB31 on phenotypic outcomes can be rigorously examined. Their use in clinical settings may further extend to personalized medicine approaches, where understanding gene function can drive treatment strategies tailored to individual patient profiles.
Compared to alternative models, RAB31 Gene Knockout Cell Lines offer several distinct advantages. They are created using advanced CRISPR/Cas9 gene-editing technology, ensuring high specificity and efficiency in gene disruption. Moreover, they provide a consistent and reproducible system for researchers looking to validate hypotheses or explore complex interactions in a controlled environment.
The value of RAB31 Gene Knockout Cell Lines is clear for researchers, clinicians, and industry professionals alike. They empower the scientific community to unravel the intricate roles of the RAB31 gene, ultimately contributing to more effective strategies for disease intervention and management.
Our company prides itself on its commitment to innovation and quality in biological research tools, ensuring our products meet the highest standards and provide essential support for groundbreaking research initiatives. With extensive expertise in genetic modifications, we stand ready to contribute to your research success with RAB31 Gene Knockout Cell Lines.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.